These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9371097)

  • 1. Plasmodium: drug discovery and development--an industrial perspective.
    Ridley RG
    Exp Parasitol; 1997 Nov; 87(3):293-304. PubMed ID: 9371097
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA launches priority vouchers for neglected-disease drugs.
    Waltz E
    Nat Biotechnol; 2008 Dec; 26(12):1315-6. PubMed ID: 19060849
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutting the cost of drug development?
    Rawlins MD
    Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
    [No Abstract]   [Full Text] [Related]  

  • 4. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J; McBurney RN
    Nat Rev Drug Discov; 2005 Dec; 4(12):961-7. PubMed ID: 16341061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: playing dirty.
    Frantz S
    Nature; 2005 Oct; 437(7061):942-3. PubMed ID: 16222266
    [No Abstract]   [Full Text] [Related]  

  • 6. Current drug development portfolio for antimalarial therapies.
    Biagini GA; O'Neill PM; Bray PG; Ward SA
    Curr Opin Pharmacol; 2005 Oct; 5(5):473-8. PubMed ID: 16084770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global portfolio of new antimalarial medicines under development.
    Olliaro P; Wells TN
    Clin Pharmacol Ther; 2009 Jun; 85(6):584-95. PubMed ID: 19404247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market watch: upcoming market catalysts in Q2 2011.
    Jeng R
    Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455226
    [No Abstract]   [Full Text] [Related]  

  • 9. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Market watch: upcoming market catalysts in Q1 of 2010.
    Rosenthal J
    Nat Rev Drug Discov; 2010 Jan; 9(1):11. PubMed ID: 20043022
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding premature licensing.
    Kessel M; Hall S
    Nat Rev Drug Discov; 2006 Dec; 5(12):985-6. PubMed ID: 17201025
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious diseases. Source of new hope against malaria is in short supply.
    Enserink M
    Science; 2005 Jan; 307(5706):33. PubMed ID: 15637249
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs - what is in use and what is in the pipeline.
    Schlitzer M
    Arch Pharm (Weinheim); 2008 Mar; 341(3):149-63. PubMed ID: 18297679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long and winding road.
    Nat Rev Drug Discov; 2005 Jun; 4(6):443. PubMed ID: 15959946
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in the clinical development of peptide therapeutics.
    Saladin PM; Zhang BD; Reichert JM
    IDrugs; 2009 Dec; 12(12):779-84. PubMed ID: 19943221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Market watch: upcoming market catalysts in Q1 2013.
    Inui E
    Nat Rev Drug Discov; 2013 Jan; 12(1):12. PubMed ID: 23274459
    [No Abstract]   [Full Text] [Related]  

  • 20. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.